Annual report pursuant to Section 13 and 15(d)

BUSINESS COMBINATIONS AND ASSET PURCHASES - Schedule of Identifiable Assets Acquired and Liabilities Assumed (Details)

v3.24.0.1
BUSINESS COMBINATIONS AND ASSET PURCHASES - Schedule of Identifiable Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 09, 2023
Dec. 31, 2022
Apr. 30, 2022
Dec. 31, 2021
Business Combination, Separately Recognized Transactions [Line Items]          
Goodwill $ 11,993   $ 8,079   $ 2,068
Kind Therapeutics USA LLC          
Business Combination, Separately Recognized Transactions [Line Items]          
Current assets, net of cash acquired       $ 5,047  
Property and equipment       622  
Goodwill       6,011  
Current liabilities       (511)  
Fair value of net assets acquired       17,952  
Kind Therapeutics USA LLC | Trade name and trademarks          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:       2,041  
Kind Therapeutics USA LLC | Licenses and customer base          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:       4,700  
Kind Therapeutics USA LLC | Non-compete agreements          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:       $ 42  
Ermont Acquisition          
Business Combination, Separately Recognized Transactions [Line Items]          
Property and equipment   $ 800      
Goodwill   3,914      
Fair value of net assets acquired   10,550      
Ermont Acquisition | Trade name and trademarks          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   1,063      
Ermont Acquisition | Customer base          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   4,642      
Ermont Acquisition | License          
Business Combination, Separately Recognized Transactions [Line Items]          
Intangible assets:   $ 131